Categories
Biogen Pharmachem Industries Ltd — Board Meeting, 14-05-2026: Board Meeting
14-05-2026 · 04:42 pm
BIOGEN PharmaChem held a board meeting. Audited FY26 results approved: Revenue Rs 2.56 Cr, Net Profit Rs 0.86 Cr. Auditors issued an unmodified opinion, a strong positive signal. Growth on the horizon?
No comments yet. Be the first to comment!